Personal Injury Lawyer -

Free case review

facebook logo google+ logo twitter logo youtube logo

Viibryd Side Effects and Pancreatitis link

viibryd pill containers

Viibryd Effects on the pancreas - FDA Warning

The powerful antidepressant medication Vilbryd has been linked with acute pancreatitis. And acute pancreatitis often leads to pancreatic cancer, which is almost always fatal.

Depression is a serious health issue that affects millions of people. The attorneys at believe, however, that choosing to treat your depression with a prescription medication should not present you with a life-or-death choice.

Yet Vilbryd, despite its links with the potentially fatal condition acute pancreatitis – and despite the fact that the U.S. Food and Drug Administration (FDA) has issued a formal waning about it – remains on the market.

On September 6, 2016, the FDA wrote a letter to Forest Labs about Viibryd. Viibryd was approved by the FDA in 2011 for the treatment of major depressive disorder in adults. By 2014 Viibryd became the third-most prescribed antidepressant.

We believe that this is an unacceptable situation.

At, we have dedicated ourselves to seeking justice for clients who have seen Big Pharma toy with their health and well-being.

Viibryd Side Effects: Acute Pancreatitis

The pancreas is one of the most important organs in the body. It produces hormones that are essential to the body’s metabolic functions, and also secretes chemicals that play essential roles in the digestion of food. The pancreas is a multitasker. Precisely because the pancreas is crucially involved with numerous, essential body functions, any damage to it can result in very serious health complications – even death.

Acute pancreatitis occurs when the pancreas suddenly becomes inflamed. The condition usually results in hospitalization, and is fatal about 10% of the time. Victims of acute pancreatitis usually endure severe pain. What is frightening is that up to 25% of patients who develop acute pancreatitis will experience a recurrent episode within the first several years. If acute pancreatitis recurs, the risk of pancreatic cancer is greatly increased. This form of cancer is almost always fatal.

Other Viibryd Side Effects

Acute pancreatitis is not the only serious side effect that has been associated with Vilbryd. This powerful antidepressant has also been connected with a host of other conditions, including but not limited to:
• diarrhea
• erectile dysfunction
• headaches
• vomiting
• dizziness
• insomnia

In the worst cases, Vilbryd has been linked with more serious conditions, such as:
• serotonin syndrome, a condition in which body temperature is elevated, muscles can tense up, and heart rates can be rendered irregular; and
• mania or hypomania, a potentially dangerous state of artificial elation or manic behavior.

Additionally the attorneys at expect new warnings related to sleep paralysis will also be added to the Viibryd label and prescribing information.
Sleep paralysis is a condition in which a person is awake but cannot move or speak. Generally, sleep paralysis occurs upon waking and lasts less than one minute. Although sleep paralysis is a serious condition, and can cause psychological harm in the most severe cases, the condition is generally not life threatening.

Viibryd and Depression

Getting your depression under control is one of the best things you can do for your health. But if controlling your depression means putting your overall health at risk – well, we think there should be other, better solutions.

If you’ve taken Vilbryd to treat your depression, you could be at serious risk and should consult your doctor immediately.

Once you’ve spoken with your doctor, contact We can help you obtain the justice and financial compensation to which we believe you are entitled.

You pay us nothing unless and until we win your case.

Call today for your free consultation.

Get Help Now!

On This Page

Articles Related To: Eliquis

Viibryd Lawsuit

Free Case Review

Call US Now!

Fill Out Form

FDA Letter:

Click Viibryd Letter To Read The Letter To The Manufacturer Of Viibryd from the FDA.

Free Case Review